The current use of CA125 measurement is in the diagnosis and monitoring of ovarian cancer and is based on measurement of a concentration threshold in serum, where levels over 30–35 U/mL are considered indicative of disease, while lower concentrations are considered in the normal range (Felder et al. 2014). This evidence concerns the gene MUC16 and ovarian cancer.